Contact this trialFirst, we need to learn more about you.
Virus Therapy
LX2020 for Arrhythmogenic Cardiomyopathy
Recruiting1 awardPhase 1 & 2
Ann Arbor, Michigan
"This trial is testing a new drug called LX2020 in adult patients with a heart condition called PKP2-ACM. The trial will determine the safety and tolerability of the drug through increasing
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.